astrazeneca cspc - Search News

News

CSPC, AstraZeneca and AI

AstraZeneca and CSPC Pharmaceuticals enter AI-driven partnership worth $5.3bn

AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for chronic conditions.

· 3d · on MSN

AstraZeneca Enters Deal With CSPC Pharma Valued at Up to $5.33 Billion

BioSpace · 3d

AstraZeneca Makes $5.3B AI Bet With China’s CSPC for Chronic Disease Pills

3hon MSN

Health Care Roundup: Market Talk

Find insight on Regis Healthcare, CSPC Pharmaceutical and more in the latest Market Talks covering the health care sector.

Fierce Biotech3d

AstraZeneca pens $5.3B pact to use CSPC's AI platform to develop oral drugs for chronic diseases

CSPC will use its artificial-intelligence-driven, dual-engine efficient drug discovery platform to analyze the binding ...

MedCity News3d

AstraZeneca Turns to CSPC Pharma Again, Putting Up $110M to Start Multi-Drug R&D Pact

AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results